JP2012532120A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012532120A5 JP2012532120A5 JP2012518140A JP2012518140A JP2012532120A5 JP 2012532120 A5 JP2012532120 A5 JP 2012532120A5 JP 2012518140 A JP2012518140 A JP 2012518140A JP 2012518140 A JP2012518140 A JP 2012518140A JP 2012532120 A5 JP2012532120 A5 JP 2012532120A5
- Authority
- JP
- Japan
- Prior art keywords
- shell structure
- composition
- drug
- contrast agent
- mpi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP09164301 | 2009-07-01 | ||
| EP09164301.5 | 2009-07-01 | ||
| PCT/IB2010/052918 WO2011001351A1 (en) | 2009-07-01 | 2010-06-25 | Stimuli-responsive carriers for mpi-guided drug delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012532120A JP2012532120A (ja) | 2012-12-13 |
| JP2012532120A5 true JP2012532120A5 (https=) | 2013-08-08 |
| JP5763631B2 JP5763631B2 (ja) | 2015-08-12 |
Family
ID=42847651
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012518140A Expired - Fee Related JP5763631B2 (ja) | 2009-07-01 | 2010-06-25 | Ｍｐｉ誘導による薬物送達のための刺激応答性キャリア |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20120100079A1 (https=) |
| EP (1) | EP2448557A1 (https=) |
| JP (1) | JP5763631B2 (https=) |
| CN (1) | CN102470098A (https=) |
| RU (1) | RU2561035C2 (https=) |
| WO (1) | WO2011001351A1 (https=) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9393198B2 (en) | 2010-03-22 | 2016-07-19 | Signpath Pharma Inc. | Intravenous curcumin and derivatives for treatment of neurodegenerative and stress disorders |
| US10238602B2 (en) | 2011-06-03 | 2019-03-26 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LysoPG and LysoPC against drugs that cause channelopathies |
| US8753674B2 (en) * | 2011-06-03 | 2014-06-17 | Signpath Pharma Inc. | Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current |
| US10117881B2 (en) | 2011-06-03 | 2018-11-06 | Signpath Pharma, Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, LYSOPG and LYSOPC against drugs that cause channelopathies |
| US10349884B2 (en) | 2011-06-03 | 2019-07-16 | Sighpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac ikr channel |
| US12004868B2 (en) | 2011-06-03 | 2024-06-11 | Signpath Pharma Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel |
| US10449193B2 (en) | 2011-06-03 | 2019-10-22 | Signpath Pharma Inc. | Protective effect of DMPC, DMPG, DMPC/DMPG, lysoPG and lysoPC against drugs that cause channelopathies |
| US10532045B2 (en) | 2013-12-18 | 2020-01-14 | Signpath Pharma, Inc. | Liposomal mitigation of drug-induced inhibition of the cardiac IKr channel |
| WO2012169973A1 (en) * | 2011-06-09 | 2012-12-13 | Agency For Science, Technology And Research | A core-shell nanoparticle |
| ITRM20120169A1 (it) | 2012-04-19 | 2013-10-20 | Consiglio Nazionale Ricerche | Dispositivo di rilascio di specie chimiche a controllo ottico |
| CA2882978A1 (en) | 2012-08-31 | 2014-03-06 | Signpath Pharma Inc. | Curcumin-er, a liposomal-plga sustained release nanocurcumin for minimizing qt prolongation for cancer therapy |
| WO2014090313A1 (en) * | 2012-12-13 | 2014-06-19 | Universitaet Ulm | Nanoparticle with a molecularly imprinted coating |
| US20150374855A1 (en) * | 2013-02-20 | 2015-12-31 | Topass Gmbh | Oral contrast medium for the diagnostic investigation of the gastrointestinal tract by means of mpi |
| CN103357027B (zh) * | 2013-08-01 | 2016-02-10 | 孙博 | 一种具有mri示踪效应的纳米微囊 |
| KR20150026613A (ko) * | 2013-09-03 | 2015-03-11 | 삼성전자주식회사 | 소수성 물질 및 조영제를 포함하는 리포좀 및 그의 용도 |
| GB201509934D0 (en) * | 2015-06-08 | 2015-07-22 | King S College London | Nanoparticles |
| AU2017257496B2 (en) | 2016-04-27 | 2020-05-07 | Signpath Pharma, Inc. | Prevention of drug-induced atrio-ventricular block |
| CN109952060B (zh) | 2016-07-12 | 2023-07-18 | 马格内蒂克因赛特公司 | 磁性粒子成像 |
| MX2019010045A (es) * | 2017-03-03 | 2019-10-02 | Baxalta Inc | Metodos para determinar la potencia de preparaciones de virus adeno-asociados. |
| KR102024273B1 (ko) | 2017-03-27 | 2019-11-04 | 주식회사 피에프디 | 약물 작용 관리 장치 및 방법 |
| US11045552B2 (en) | 2017-04-04 | 2021-06-29 | International Business Machines Corporation | Stimulus-responsive micellar carrier |
| CN107320738B (zh) * | 2017-07-12 | 2020-06-12 | 福州大学 | 一种四氧化三锰-乳白蛋白纳米球及其制备与应用 |
| JP6934833B2 (ja) | 2018-03-30 | 2021-09-15 | 三菱パワー株式会社 | 水質モニタリングシステムとそれを備えた蒸気タービンシステム、並びに水質モニタリング方法 |
| US11890488B2 (en) | 2019-03-13 | 2024-02-06 | Magnetic Insight, Inc. | Magnetic particle actuation |
| CN112043682B (zh) * | 2020-09-19 | 2022-03-11 | 新乡医学院 | 一种基于多孔钆掺杂氧化铁纳米簇的磁性纳米药物载体及其制备方法 |
| US11839458B2 (en) | 2021-02-08 | 2023-12-12 | Vanberbilt University | Magnetic particle imaging using an ultrasonic driving field |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5411730A (en) * | 1993-07-20 | 1995-05-02 | Research Corporation Technologies, Inc. | Magnetic microparticles |
| US5534499A (en) | 1994-05-19 | 1996-07-09 | The University Of British Columbia | Lipophilic drug derivatives for use in liposomes |
| US6726925B1 (en) | 1998-06-18 | 2004-04-27 | Duke University | Temperature-sensitive liposomal formulation |
| US6835394B1 (en) | 1999-12-14 | 2004-12-28 | The Trustees Of The University Of Pennsylvania | Polymersomes and related encapsulating membranes |
| US7672704B2 (en) * | 2002-09-11 | 2010-03-02 | Duke University | Methods and compositions for blood pool identification, drug distribution quantification and drug release verification |
| US8097283B2 (en) * | 2004-01-15 | 2012-01-17 | Mount Sinai School Of Medicine | Methods and compositions for imaging |
| WO2005077330A1 (en) * | 2004-02-17 | 2005-08-25 | The University Of Melbourne | Electromagnetic radiation addressable materials |
| EP1738773A1 (de) * | 2005-06-29 | 2007-01-03 | Schering AG | Magnetische Eisenoxidpartikel enthaltende Zusammensetzung und deren Vervendung in bildgebenden Verfahren |
| TWI314465B (en) * | 2005-12-30 | 2009-09-11 | Ind Tech Res Inst | Thermosensitive nanostructure for hyperthermia treatment |
| CZ301067B6 (cs) * | 2006-02-24 | 2009-10-29 | Ústav makromolekulární chemie AV CR | Superparamagnetické nanocástice na bázi oxidu železa s modifikovaným povrchem, zpusob jejich prípravy a použití |
| KR20080035926A (ko) * | 2006-10-20 | 2008-04-24 | 재단법인서울대학교산학협력재단 | 자성체 나노입자를 함유한 코어-외각 구조의 금 나노입자의자기공명영상의 티2 조영제, 암 진단제 및 암치료제로서의 용도 |
| WO2008099346A1 (en) * | 2007-02-16 | 2008-08-21 | Koninklijke Philips Electronics N. V. | Method and separator system for separating magnetic particles, separator column for use in a separator system |
| JP2009051752A (ja) * | 2007-08-24 | 2009-03-12 | Hitachi Ltd | 磁性粒子含有薬剤キャリア及びそれを用いた治療装置 |
| US9216220B2 (en) * | 2008-04-10 | 2015-12-22 | Board Of Regents, The University Of Texas System | Compositions and methods for thermo-sensitive nanoparticles and magnetic nanoparticles |
| TWI374761B (en) * | 2008-05-13 | 2012-10-21 | Univ Nat Chiao Tung | Method for forming a drug container having the magnetic nano single-crystalline capsule |
-
2010
- 2010-06-25 CN CN2010800299507A patent/CN102470098A/zh active Pending
- 2010-06-25 RU RU2012103347/15A patent/RU2561035C2/ru not_active IP Right Cessation
- 2010-06-25 WO PCT/IB2010/052918 patent/WO2011001351A1/en not_active Ceased
- 2010-06-25 EP EP10733045A patent/EP2448557A1/en not_active Withdrawn
- 2010-06-25 JP JP2012518140A patent/JP5763631B2/ja not_active Expired - Fee Related
- 2010-06-25 US US13/379,056 patent/US20120100079A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012532120A5 (https=) | ||
| Viger et al. | Collective activation of MRI agents via encapsulation and disease-triggered release | |
| RU2012103347A (ru) | Восприимчивые к стимулирующему фактору носители для вмч-регулируемой доставки лекарственного средства | |
| Kumar et al. | Magnetic nanomaterials for hyperthermia-based therapy and controlled drug delivery | |
| Chiozzi et al. | Inorganic–organic core/shell nanoparticles: progress and applications | |
| Levy et al. | Nanochemistry: synthesis and characterization of multifunctional nanoclinics for biological applications | |
| JP2015532928A5 (https=) | ||
| Sharma et al. | An insight into functionalized calcium based inorganic nanomaterials in biomedicine: Trends and transitions | |
| Bertrand et al. | The journey of a drug-carrier in the body: an anatomo-physiological perspective | |
| Sun et al. | Nano‐biomedicine based on liquid metal particles and allied materials | |
| JP5266548B2 (ja) | 磁性ナノ粒子組成物およびその使用 | |
| Sharma et al. | Gd nanoparticulates: from magnetic resonance imaging to neutron capture therapy | |
| JP2011525477A5 (https=) | ||
| JP2013503831A5 (https=) | ||
| JP2015509079A5 (https=) | ||
| Osei-Yeboah et al. | Tabletability modulation through surface engineering | |
| Xu et al. | Advances in brain tumor therapy based on the magnetic nanoparticles | |
| JP2011524890A5 (https=) | ||
| JP2015522548A (ja) | ツーピース硬カプセル用の耐酸性バンド溶液 | |
| JP2016505006A5 (https=) | ||
| JP2010536898A5 (https=) | ||
| MX351866B (es) | Entrega de compuestos funcionales. | |
| Dunn et al. | Recent developments in the design of nanomaterials for photothermal and magnetic hyperthermia induced controllable drug delivery | |
| JP2018502150A5 (https=) | ||
| JP2015510935A5 (https=) |